DrugPatentWatch Database Preview
Investigational Drug Information for Galactose
Email this page to a colleague
What is the drug development status for Galactose?
Galactose is an investigational drug.
There have been 25 clinical trials for Galactose.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2012.
The most common disease conditions in clinical trials are Syndrome, Mucopolysaccharidosis IV, and Mucopolysaccharidoses. The leading clinical trial sponsors are BioMarin Pharmaceutical, University of Aarhus, and Applied Therapeutics, Inc.
There are four hundred and forty-nine US patents protecting this investigational drug and twenty-three international patents.
Summary for Galactose
| US Patents | 449 |
| International Patents | 23,637 |
| US Patent Applications | 5,798 |
| WIPO Patent Applications | 485 |
| Japanese Patent Applications | 33 |
| Clinical Trial Progress | Phase 3 (2012-09-01) |
| Vendors | 43 |
Recent Clinical Trials for Galactose
| Title | Sponsor | Phase |
|---|---|---|
| Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia | Applied Therapeutics, Inc. | Phase 2/Phase 3 |
| A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human <=-Galactosidase in Type II GM1 Gangliosidosis | Axovant Sciences, Inc. | Phase 1/Phase 2 |
| A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human <=-Galactosidase in Type II GM1 Gangliosidosis | National Human Genome Research Institute (NHGRI) | Phase 1/Phase 2 |
Clinical Trial Summary for Galactose
Top disease conditions for Galactose
Top clinical trial sponsors for Galactose
US Patents for Galactose
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Galactose | ⤷ Sign up for a Free Trial | Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, MA) | ⤷ Sign up for a Free Trial |
| Galactose | ⤷ Sign up for a Free Trial | Ophthalmic emulsion | Alcon Research, Ltd. (Ft. Worth, TX) | ⤷ Sign up for a Free Trial |
| Galactose | ⤷ Sign up for a Free Trial | Peptide pharmaceuticals | EUMEDERIS PHARMACEUTICALS, INC. (San Diego, CA) | ⤷ Sign up for a Free Trial |
| Galactose | ⤷ Sign up for a Free Trial | Recombinant microalgae including keto-acyl ACP synthase | Corbion Biotech, Inc. (South San Francisco, CA) | ⤷ Sign up for a Free Trial |
| Galactose | ⤷ Sign up for a Free Trial | Dual molecular delivery of oligonucleotides and peptide containing conjugates | Merck Sharp & Dohme Corp. (Rahway, NJ) | ⤷ Sign up for a Free Trial |
| Galactose | ⤷ Sign up for a Free Trial | Peptide pharmaceuticals | EUMEDERIS PHARMACEUTICALS, INC. (San Diego, CA) | ⤷ Sign up for a Free Trial |
| Galactose | ⤷ Sign up for a Free Trial | TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs) | YALE UNIVERSITY (New Haven, CT) | ⤷ Sign up for a Free Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Galactose
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Galactose | Argentina | AR104674 | 2035-04-21 | ⤷ Sign up for a Free Trial |
| Galactose | Australia | AU2016252737 | 2035-04-21 | ⤷ Sign up for a Free Trial |
| Galactose | Brazil | BR112017022715 | 2035-04-21 | ⤷ Sign up for a Free Trial |
| Galactose | Canada | CA2999843 | 2035-04-21 | ⤷ Sign up for a Free Trial |
| Galactose | European Patent Office | EP3285797 | 2035-04-21 | ⤷ Sign up for a Free Trial |
| Galactose | World Intellectual Property Organization (WIPO) | WO2016172319 | 2035-04-21 | ⤷ Sign up for a Free Trial |
| Galactose | Australia | AU2014261788 | 2033-04-29 | ⤷ Sign up for a Free Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
